[1]
Jeesa George 2022. Pharmacovigilance During Pre-Approval Phases -Comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP and CDSCO Risk Management Guidelines. International Journal of Progressive Research in Science and Engineering . 3, 07 (Jul. 2022), 80–86.